Literature DB >> 32633774

Refractory Hypotension During General Anesthesia Despite Withholding Telmisartan.

Takayuki Hojo1, Makiko Shibuya1, Yukifumi Kimura1, Yuki Otsuka1, Toshiaki Fujisawa1.   

Abstract

Angiotensin receptor blockers (ARBs) are commonly used to treat hypertension. However, similar to angiotensin-converting enzyme inhibitors, ARBs can also cause refractory hypotension during general anesthesia. Therefore, it has been recommended that ARBs be withheld for 24 hours prior to the induction of anesthesia. This is a case report of refractory hypotension requiring the administration of potent vasopressors after the induction of general anesthesia despite withholding telmisartan for 24 hours. In the same patient undergoing a subsequent general anesthetic, telmisartan was withheld for 5 days before induction, leading to mild intraoperative hypotension that responded adequately to phenylephrine. The primary cause of refractory hypotension during the first general anesthetic was suspected to be an insufficient telmisartan washout period. Telmisartan's half-life of 24 hours is notably the longest of all ARBs in current use. This case report demonstrates that refractory hypotension during general anesthesia cannot always be avoided by withholding telmisartan for 24 hours before the induction of anesthesia. Therefore, a washout period greater than 24 hours is preferable for patients taking telmisartan.
© 2020 by the American Dental Society of Anesthesiology.

Entities:  

Keywords:  Anesthesia induction; Angiotensin receptor blockers; Refractory hypotension; Telmisartan; Washout period

Mesh:

Substances:

Year:  2020        PMID: 32633774      PMCID: PMC7342806          DOI: 10.2344/anpr-67-02-02

Source DB:  PubMed          Journal:  Anesth Prog        ISSN: 0003-3006


  13 in total

Review 1.  Management of hypotension associated with angiotensin-axis blockade and general anesthesia administration.

Authors:  Berend Mets
Journal:  J Cardiothorac Vasc Anesth       Date:  2012-07-31       Impact factor: 2.628

2.  Should the angiotensin II antagonists be discontinued before surgery?

Authors:  M Bertrand; G Godet; K Meersschaert; L Brun; E Salcedo; P Coriat
Journal:  Anesth Analg       Date:  2001-01       Impact factor: 5.108

3.  Withholding versus Continuing Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers before Noncardiac Surgery: An Analysis of the Vascular events In noncardiac Surgery patIents cOhort evaluatioN Prospective Cohort.

Authors:  Pavel S Roshanov; Bram Rochwerg; Ameen Patel; Omid Salehian; Emmanuelle Duceppe; Emilie P Belley-Côté; Gordon H Guyatt; Daniel I Sessler; Yannick Le Manach; Flavia K Borges; Vikas Tandon; Andrew Worster; Alexandra Thompson; Mithin Koshy; Breagh Devereaux; Frederick A Spencer; Robert D Sanders; Erin N Sloan; Erin E Morley; James Paul; Karen E Raymer; Zubin Punthakee; P J Devereaux
Journal:  Anesthesiology       Date:  2017-01       Impact factor: 7.892

Review 4.  Low-Dose Vasopressin and Analogues to Treat Intraoperative Refractory Hypotension in Patients Prescribed Angiotensin-Converting Enzyme Inhibitors Undergoing General Anesthesia: A Systematic Review.

Authors:  Kara F Hedman; Carrie L Mann; Cheryl Spulecki; Jessica Castner
Journal:  AANA J       Date:  2016-12

Review 5.  A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists.

Authors:  Martin C Michel; Carolyn Foster; Hans R Brunner; Lisheng Liu
Journal:  Pharmacol Rev       Date:  2013-03-13       Impact factor: 25.468

6.  Chronic Renin-Angiotensin System (RAS) Blockade May Not Induce Hypotension During Anaesthesia for Bariatric Surgery.

Authors:  Guido Salvetti; Claudio Di Salvo; Giovanni Ceccarini; Antonio Abramo; Paola Fierabracci; Silvia Magno; Paolo Piaggi; Paolo Vitti; Ferruccio Santini
Journal:  Obes Surg       Date:  2016-06       Impact factor: 4.129

7.  A Systematic Review of Outcomes Associated With Withholding or Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Before Noncardiac Surgery.

Authors:  Caryl Hollmann; Nicole L Fernandes; Bruce M Biccard
Journal:  Anesth Analg       Date:  2018-09       Impact factor: 5.108

8.  Neurocirculatory responses to sevoflurane in humans. A comparison to desflurane.

Authors:  T J Ebert; M Muzi; C W Lopatka
Journal:  Anesthesiology       Date:  1995-07       Impact factor: 7.892

Review 9.  Beta-blockers in noncardiac surgery: Did observational studies put us back on safe ground?

Authors:  M E Jørgensen; C Andersson; S Venkatesan; R D Sanders
Journal:  Br J Anaesth       Date:  2018-03-20       Impact factor: 9.166

10.  Refractory hypotension during general anesthesia despite preoperative discontinuation of an angiotensin receptor blocker.

Authors:  Raha Nabbi; Harvey J Woehlck; Matthias L Riess
Journal:  F1000Res       Date:  2013-01-14
View more
  1 in total

1.  Prolonged Washout Period for Avoiding Azilsartan-Induced Refractory Hypotension During General Anesthesia for a Patient With Renal Impairment.

Authors:  Takayuki Hojo; Yukifumi Kimura; Keiji Hashimoto; Takahito Teshirogi; Toshiaki Fujisawa
Journal:  Anesth Prog       Date:  2021-12-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.